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ABSTRACT
Objective To devise strategies to amend lay and 
practitioner atopic eczema mindlines ‘collectively 
reinforced, internalised tacit guidelines’, to improve 
consultation experiences and self- management practices 
in primary care.
Design Co- creation workshops informed by the Co:Create 
Coproduction Matrix.
Setting Conference centre in central England and via 
remote communication.
Participants Lay people with, and parents of children 
with, atopic eczema, practitioners, a researcher and a 
facilitator (n=22).
Results Eczema mindline amendment needs to address 
people and parents of children with the condition, 
practitioners and wider society in parallel. For lay people 
trust and ‘realness’ of amendment activity was vital and 
practitioners wanted practical, locally relevant, hints and 
tips, tailored, ‘no faff’ approaches. To improve consultation 
experiences and self- management practices, five key, 
consistent, evidence- based messages need to be instilled 
into eczema mindlines: (1) eczema is more than just dry 
skin, (2) eczema does not just go away, (3) moisturisers 
are for every day, (4) steroid creams are okay when you 
need them and (5) you know your child’s eczema best.
Conclusion This co- creation study provides original 
insights into what eczema knowledge should be mobilised, 
who needs to have this knowledge, how this should 
be achieved to amend existing mindlines to improve 
consultation experiences and self- management practices 
in primary care.
The remaining challenge is to refine, implement and 
evaluate the effectiveness of strategies developed to instil 
the five core messages and erase outdated or inaccurate 
information.
INTRODUCTION
Atopic eczema (hereafter eczema) is a 
common burdensome long- term skin condi-
tion1 with a high self- management demand.2 
Evidence- based treatment guidance is 
available, for example, from the National 
Institute for Health and Clinical Excellence3 
and Clinical Knowledge Summaries.4 The 
mainstay of treatment is use of topical corti-
costeroids (TCS) at times of flare and regular, 
consistent application of emollients even 
when the skin appears healthy; in essence 
‘getting control and keeping control’.5 
Eczema management is 97% primary care 
based in the UK.6 Primary care consultations 
are often unsatisfactory for patients and prac-
titioners alike.7 8 Patients report practitioners 
with limited knowledge9 and dismissive atti-
tudes.10 Some practitioners describe uncer-
tainity about optimum treatment11 ; others 
regard eczema as simple to treat and perceive, 
no need to change their current treatment 
‘recipe’.12 A particular challenge is ensuring 
safe and appropriate use of TCS. Steroid 
phobia is common13 and reinforced at many 
levels12 14 potentially leading to under treat-
ment, unwarranted suffering or treatment 
escalation15 and wastage of prescribed medi-
cation.16 Eczema is a long- term condition, 
often with a high self- management demand. 
Long- term condition self- management is 
a policy imperative.17–19 Definitions of self- 
management vary20 but involve ongoing 
efforts to maintain or improve health. 
Strengths and limitations of this study
 ► First co- creation study to examine strategies to 
amend lay–practitioner social atopic eczema 
mindlines.
 ► Diverse lay and practitioner co- creation group .
 ► Only those with an existing interest in eczema joined 
the co- creation group.
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Self- management interventions are designed to increase 
a person’s capacity, confidence and efficacy of to perform 
the necessary activities.21 Self- management of long- term 
skin conditions is notoriously challenging.22 Supportive 
interventions include bespoke programmes23 and educa-
tional and psychological interventions.24–26 However, such 
offerings are not available to all, are costly and impact is 
inconsistent.23
Knowledge mobilisation (KM) is essentially ‘moving 
knowledge to where it can be most useful’27 ; it involves 
deliberative actions to create, disseminate and opera-
tionalise research and other forms of knowledge.28 KM is 
context specific,29 relational30 and socially constructed.31 
One approach to mobilising knowledge is through 
amending mindlines.12 14 32 Mindlines are ‘collectively 
reinforced, internalised tacit guidelines’, which underpin 
clinical decision- making.33 They are built on a multifac-
eted combination of knowledge sources such as commu-
nication with colleagues and opinion leaders in the field 
and from personal tactic knowledge developed over 
time.33 Mindlines are founded in the work of Polyani34 
and Nonaka and Takeuchi35 ; these authors recognise 
that knowledge is not necessarily conscious and explicit, 
but is in large part tacit and created from technical 
know- how and unconscious schemata. In practice, this 
tacit knowledge is a far more influential than formal codi-
fied knowledge.
The seminal mindlines paper of Gabbay and le May36 
has been cited 945 times to date. An extensive review a 
decade later37 reveals that little attention has been paid to 
condition specific mindlines or to a patient equivalent to 
mindlines, although Gabbay and le May33 intimate their 
existence that they do not develop this notion. Repeating 
the review search strategy reveals a continued absence of 
focus on patient mindlines with the exception of recent 
ethnographic work by one of the authors of this paper 
(FC), elucidating lay and practitioner eczema mind-
lines.12 14 32 These studies advocate improving eczema 
consultation experiences and self- management prac-
tices in primary care through a concerted effort amend 
eczema mindlines to increase shared knowledge, under-
standing and decision- making. It is proposed that this 
may be achieved through parallel lay and practitioner 
mindline amendment.
Mindline amendment requires collaborative efforts 
from lay people, that is, people with and parents of chil-
dren with eczema, practitioners and researchers. Figure 1 
illustrates the fundamentals of eczema mindlines and 
shows the complexity of how knowledge is gained, from 
which sources and the inter- relationship between lay–
practitioner wider society mindlines. In essence, (1) lay 
people gain knowledge and beliefs from many sources, for 
example, personal experience, family, friends and wider 
society, trial and error, online and from practitioners14 ; 
and (2) practitioner actions are underpinned by a belief 
that eczema is simple to treat ‘the recipe does not change’ 
and that treatment options are limited by prescribing 
guidance, knowledge is accrued from early education, 
colleagues, practical experience and patients.12 Further 
work illuminates the inter- relationship between the 
two and therefore the need for efforts to amend mind-
lines to be a shared venture which transcends lay–prac-
titioner boundaries and instils shared and consistent 
understanding.32
Co- methodologies in healthcare are increasingly consid-
ered to be a ‘good thing’. The language of ‘coworking’ 
remains contested.38 39 There is a multitude of models 
but it is increasingly considered that coworking should 
involve lay people and professionals working as equals at 
every stage of the research process.39 40 Essential questions 
Figure 1 Lay (left side) and practitioner (right side) eczema mindlines and inter- relationship between the two.
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when planning co- creation include ‘who is participating, 
in what and for whose benefit’.41
In light of the prevalence of eczema, the high self- 
management demand, the challenges of primary care 
consultations and recent developments in understand-
ings of lay and practitioners eczema mindlines,12 14 32 it 
seems prudent to investigate the way in which co- creation 
may be used to devise novel approaches to influence 
these mindlines. The intention is to mobilise relevant, 
accurate, up to date and contextually appropriate knowl-
edge to support positive primary care consultations and 




To devise strategies to amend lay and practitioner eczema 
mindlines to improve consultation experiences and self- 
management practices in primary care.
Objectives
1. To agree what a good consultation and effective self- 
management looks like.
2. To identify
1. What knowledge needs to be mobilised.
2. Who needs this knowledge.
3. How should this knowledge be shared.
Design
We employed a co- creation approach informed by the 
‘Gold Standard’ Coproduction Matrix.40 which comprises 
eight principles as summarised in box 1.
Setting, co-creators and process
The co- creation group was recruited via a central England 
Higher Education Institute website with mass sharing via 
word of mouth and media posts, professional networks 
and an existing dermatology patient panel. Maximum 
variation purposive sampling42 was applied in selecting 
co- creators of different age, gender and ethnicity, with 
experience of giving or receiving eczema care, ensuring 
a balance of lay and practitioner participants (n=22). 
Potential co- creators were sent an information sheet. 
Those who agreed to take part received a copy of the orig-
inal mindline publication of Gabbay and le May36 and a 
copy of the lay and practitioner eczema mindline illus-
trations together with a brief explanation of how these 
had been developed and confirmed. The group met 
for a series of three face- to- face workshops and iterative 
email exchanges between April 2018 and March 2019. 
Workshops took place outside usual working hours at 
an accessible conference centre. The researcher (FC) 
and facilitator (CL), both of whom are experienced in 
co- creation, attended all three workshops. Practitioners 
attended workshop one, lay people with eczema, or who 
had children with eczema, attended workshop two and 
the full group attended workshop three. Following each 
workshop, data were summarised and emailed to group 
members for discussion and approval. After the third 
workshop, final refinement of ideas and terminology for 
key messages was achieved via email.
Although co- creators were nominally either lay or 
professional there was a degree of overlap, for example, 
two of the practitioners had children with eczema and 
one lay person was also a practitioner. Demographic 
details are summarised in table 1.
Data collection
Data collected included: facilitator notes written 
throughout the session, summaries of individual and 
group presentation information recorded on flip chart, 
checked by group members at the time of writing and 
artefacts, for example, group member notes and products 
from activities. Details of workshops are summarised in 
table 2.
Data analysis
Data collection and analysis were iterative processes.43 
The researcher (FC) transcribed data from workshops 
and reviewed this as whole prior to summarising. 
FC and CL analysed the data summaries identifying 
key points and potential areas for mindline amend-
ment as generated by the group. We paid attention to 
areas of agreement and disagreement between indi-
viduals and groups and circulated data summaries to 
group members for comment, supplementation and 
modification.
Reflexivity
A reflexive stance was maintained for the duration of 
the study with particular consideration being given 
to subjectivity and positioning of the researcher as 
a nurse with a particular interest in skin health; pre- 
understandings were consciously set aside.44
Box 1 Eight principles of the Co:Create Coproduction 
Matrix
 ► Holistic: Coproduction should happen at every stage.
 ► Resourced: Meaningful and effective coproduction deserves and re-
quires sufficient resource.
 ► Transparent: Coproduction should have a clear and transparent re-
mit that is,: overall aims, limitations, expectations and commitment.
 ► Inclusive: Coproduction should involve a wide range of people (eg, 
practitioners, customers, future users, the wider community), cap-
turing individual and differing views.
 ► Iterative: Coproduction should be reciprocal, repeated and progres-
sive, always adapting and building uponon what came before.
 ► Positive: Coproduction should be mutually beneficial and an overall 
positive experience.
 ► Equal: Each participant and their contribution should be valued 
equally.
 ► Sustainable: Meaningful coproduction should have a genuine sus-
tainable impact on the project.
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Patient and public involvement
Lay people were involved in the development of the 
research question, planning and delivering the study and 
disseminating results.
RESULTS
The co- creation group addressed four question. Each is 
discussed below with explanatory examples from the data.
1. What makes a good eczema consultation in primary 
care?
Lay group members suggested that a good consultation 
for them required a practitioner who understood the 
impact of eczema on their lives and had time to discuss 
these issues, ‘usually not enough time to talk about the 
condition, how it effects life, more talking and under-
standing would be a good consultation’. Honesty about 
their knowledge was valued even when limited, provided 
they ‘point us to useful information, the right direction 
and resources’. In parallel was the need for practitioners 
to respect individual’s expertise in their own condition, ‘I 
have an understanding, long- term and understand when 
I need help and something different’. Group members 
wanted to see the same practitioner when possible to 
avoid feeling ‘sick and tired of saying the same story 
over and over again’. They wanted practitioners to take 
eczema seriously, think of it as a long- term condition, ‘to 
help manage ‘long- term’ rather than short- terms solu-
tion for flares’. Group members accepted their role in 
self- management with even the youngest stating the need 
for ‘taking responsibility and sharing responsibility for 
condition……… makes you grow up’. While embracing 
their contribution to long- term eczema control group 
members wanted to work with practitioners and to 
‘come to an understanding, work together, look at self- 
management…but…be there for support if needed’. 
They desired a sense of ‘we can manage this, do not want 
to feel alone’.
For practitioners, a good eczema consultation was 
characterised by empathy, with two- way dialogue between 
‘equals’ to generate shared understanding of eczema 
and treatment history asking ‘tactful questions’ so that 
both parties understand and ‘play the same tune, be 
on the same page’. Consistency in message from prac-
titioners reduced misunderstandings and enhanced 
patient’s confidence. They spoke of the long- term 
nature of eczema and the need to be ‘blunt (honest!)’ 
about the need to ‘explain long- term use of emollients 
to avoid flares’. Agreeing goals to ‘get control and keep 
control’ was pivotal, with some advocating the provision 
of written information including action plans. Strategies 
to ‘work with patients and motivate them to use emol-
lients’ and ‘emphasising long- term gain’ were promoted. 
It was important to find the ‘right’ emollient. Being 
flexible to patient preference and experience was vital, 
although difficult within the confines of local prescribing 
guidelines.
2. What should lay people and practitioners start, stop 
and continue to improve eczema consultations and 
self- management?
Co- creators identified the aspects of consultations that 
should be started, stopped and continued from both 
perspectives. Common threads included the need for a 
long- term approach to care, being prepared for the consul-
tation, prioritising eczema, shared decision- making and 
consistent use of topical treatments (see online supple-
mental information 1 for more detail). Of note was that 
the group agreed that general practitioners (GPs) were 
not necessarily the right practitioner to manage eczema 
and that more attention needs to be given to the role of 
other professionals, specifically community pharmacists, 
pharmacy counter assistants, nurses and health visitors.
3. What are the priority areas for lay and practitioner 
eczema mindline amendment?
Distillation of data collected from the first two work-
shops and associated email exchanges identified seven 
key areas for mindline amendment: (1) prioritise eczema, 
(2) manage eczema as a long- term condition, (3) prepare 
for each consultation, (4) be consistent with treatment, 
(5) work together, (6) get the right emollient and (7) use 
steroids appropriately. The facets of each area for mind-
line amendment are summarised in table 3. Each area was 
viewed from both lay and practitioner perspectives.
Following a consensus activity, the group prioritised 
three areas for mindline amendment: (1) manage eczema 
Table 1 Demographic details of the co- creation group
Role Gender Age range
Lay person F 35–44
Lay person M Under 16
Lay person F Under 16
Lay person M Over 55
Lay person F Over 55
Lay person F 25–34
Lay person F 45–54
Lay person F 25–34
Lay person F 45–54
Lay person F 35–44
Dermatology specialist nurse F 45–54
General practitioner F 25–34
General practitioner trainee M 25–34
Practice nurse F 45–54
Medical student F 17–24
Pharmacist M 25–34
General practitioner trainee F 25–34
Primary care nurse F 45–54
Pharmacist M 45–54
Pharmacy counter assistant F 35–44
Facilitator F 45–54
Researcher, facilitator and nurse F 45–54
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as a long- term condition, (2) work together and (3) use 
topical steroids appropriately.
4. How may lay and practitioner eczema mindlines best 
be amended?
The group highlighted challenges in modifying mind-
lines. These included the belief that eczema is not a priority 
for practitioners, some beliefs are deeply entrenched, 
and some reluctance to engage in shared decision- 
making. In essence amendment activities suggested were 
multifaceted. As each idea was proposed, pros and cons 
were identified and many discounted as not feasible for 
reasons such as lack of resources, for example, time and 
funding.
All agreed that interventions to amend the mindlines of 
either group in isolation would not be effective as they are 
inextricably linked. Co- creators identified the influence 
of wider social influences on beliefs about eczema care, 
for example, in promulgating powerful messages, such as 
children ‘grow out of eczema’ and the myth that topical 
steroid preparations are necessarily ‘dangerous’. For this 
Table 3 Priorities for and facets of eczema mindline amendment
Priorities for mindline amendment Facets
Prioritise eczema Be attentive, make eczema the primary reason for consultation, offer or go for follow- up.
Manage eczema as a long- term 
condition
Educate, explain, avoid quick fixes, do not expect a cure, ‘get control, keep control’.
Prepare for each consultation Be aware of patient history, offer facts and good explanation, plan what to say, know 
what you want to achieve.
Be consistent with treatment Be concordant, know products and how to use them, agree realistic regimens, be 
truthful, do not waste, try over the counter products, understand local formulary.
Work together Listen and question, acknowledge expertise, understand burden of treatment, plan, get 
control, keep control.
Get the right emollient Be familiar with products, offer choice, agree feasible regimen.
Use topical steroids appropriately Understand risk and benefits, use for flares, use the best product for the optimum time.
Table 2 Details of co- creation workshops
Workshop Attendees Time Activity
1 Practitioners, researcher and 
facilitator
2.5 hours  ► Introductions and clarification of purpose of workshop.
 ► Discussion and questions about the circulated article and eczema 
mindlines illustrations.
 ► Selection from a choice of ordinary postcards that co- creators 
thought represented a ‘good’ eczema consultation; each person 
briefly presented their thoughts.
 ► Small group exercise to identify behaviours that patients and 
practitioners should start, stop and continue to bring about an 
improvement in eczema consultations and self- management.
 ► Identification of initial priorities for mindline amendment.
2 Lay people, researcher and 
facilitator
3 hours  ► As above.
3 Lay people, practitioners, 
researcher and facilitator
1 day  ► Introductions and clarification of purpose of workshop.
 ► Recap and discussion about the process and outcomes of 
workshops one and two.
 ► Co- creators individually reviewed priorities for mindline amendment 
derived from sessions 1 and 2 (table 3) and ranked these in order 
of which they considered most likely to lead to improvement in 
consultation experience and self- management.
 ► Individuals worked in three mixed subgroups to identify their top 
three priorities.
 ► Whole group reconvened and each subgroup presented their 
rationale and choice for their top three after which, through 
consensus activity, a final three priorities for action were agreed.
 ► Subgroups worked with a range of creative resources to 
contemplate how lay and practitioner eczema mindlines may best 
be amended.
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reason, they suggested that any attempt to amend mind-
lines would have to address all key players in parallel. For 
lay people trust and ‘realness’ of amendment, activity was 
vital and practitioners wanted practical, locally relevant, 
hints and tips, tailored, ‘no faff’ approaches.
While amendment of knowledge was deemed 
important, the group was unanimous in agreeing that 
providing information alone is not sufficient. There is 
also a need to redress power imbalances between patient 
and practitioner and promote shared understanding and 
decision- making. With this in mind, email exchanges with 
co- creators resulted in the three priorities being trans-
lated into five key, consistent, evidence- based messages: 
(1) eczema is more than just dry skin, (2) eczema does 
not just go away, (3) moisturisers are for every day, (4) 
steroid creams are okay when you need them and (5) 
you know your child’s eczema best. The latter was added 
as it was considered that initial mindline amendment 
activity should be targeted and, given the prevalence of 
childhood eczema, this was a reasonable focus. It also 
acknowledges the importance of parents’ knowledge and 
expertise. Each priority is underpinned by a set of simple, 
illustrated messages (online supplemental information 
2). Given the need for consistency, clarity and straight-
forwardness of messages, at this stage we revisited existing 
evidence- based resources including National Institute for 
Health and Care Excellence (NICE) guidance,3 clinical 
knowledge summaries (CKS)4 and also consulted with 
the National Eczema Society to ensure consistency and fit 
with existing evidence base.
Co- creators worked with a range of resources to develop 
potential methods of amending lay and practitioner 
eczema mindlines; initial ideas for further development 
are summarised in box 2.
DISCUSSION
The aim of this co- creation study was to devise strate-
gies to amend lay and practitioner eczema mindlines to 
improve consultation experiences and self- management 
practices in primary care. Amending mindlines offers 
an entirely new approach to changing eczema care, 
which goes beyond existing education interventions for 
patients and parents.23–26 It also addresses the identified 
challenges of primary care practitioners not prioritising 
their own eczema education.12 In co- creation, particular 
emphasis was placed on defining what knowledge needs 
to be mobilised, who needs this knowledge and how should 
this knowledge be shared. These questions were answered 
through a series of structured co- creation workshops and 
virtual communications.
What knowledge needs to be mobilised? Although most 
lay people and practitioners know the fundamental ‘ingre-
dients’ of eczema care are TCS and emollients, it is knowl-
edge about the nuanced ‘recipe’ for most effective use 
that needs to be amended. Alongside this, the long- term 
nature of eczema and the need for mutual understanding 
between lay person and practitioner must be understood. 
Who needs this knowledge? Mindline amendment activity 
needs to be comprehensive, engaging people and parents 
of children with the condition, the full gamut of practi-
tioners and people in wider society who may influence 
eczema care. How should this knowledge be shared? 
Importantly, knowledge alone is not sufficient to improve 
consultation experiences and self- management practices. 
There is a parallel need to change the balance of power 
in patient–practitioner relationships. These results are 
reflected in the five key messages to underpin eczema 
mindline amendment (see above).
This original study is one of the first to investigate how 
condition specific mindlines may best be amended across 
lay–practitioner social boundaries. A robust approach 
to co- creation is demonstrated thorough adherence to 
the Gold Standards for co- creation.40 In particular, the 
process was well resourced, the group was diverse in terms 
of age, gender, ethnicity and expertise and was able to 
agree mutual aims and objectives and consistently and 
equally work together to achieve these. The co- creative 
process was reciprocal and progressive, steadily building 
on previous work to develop a sustainable approach to 
eczema mindline amendment. Reporting is in accor-
dance with the consolidated criteria for reporting qual-
itative research.45
Limitations are twofold, first only those with an interest 
in eczema were likely to take part, thus neglecting the 
many people who do not prioritise eczema care. Second, 
face- to- face co- creative time was limited, but this was 
mitigated by skilled facilitation, careful planning to 
ensure best use was made of available time and by using 
follow- up emails and conversations for clarification and 
development.
The need to address knowledge deficits, embrace 
key influencers across lay–practitioner social bound-
aries and power imbalances led to the development 
of five key messages together with potential modes of 
delivery intended to bring about widespread changes 
in eczema mindlines. These are discussed in relation to 
the existing literature. Findings from this present study 
reflect existing research that reports poor consultation 
Box 2 Initial ideas for mindline amendment strategies
 ► Holding ‘pop ups’ of eczema information in places not currently 
targeted.
 ► Having simple information available in skin care sections of 
supermarkets.
 ► Targeting information at ‘Health Living Pharmacies’.
 ► Using ‘Steroid Sam the emoji’ in information to illustrate topical ste-
roids in a more positive light.
 ► Making more use of the Patient Oriented Eczema Measure/Children’s 
Dermatology Life Quality Index so parents can be more confident in 
‘proving’ impact of eczema during consultations.
 ► Offering a ‘recipe’ for better skin.
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experiences, practitioners with limited knowledge and 
apparent apathy and lack of priority given to eczema 
management by both some lay people and some prac-
titioners.9–11 This mirrors the state of ‘gloom à deux’ in 
which patients and practitioners share a perception of 
hopelessness,46 which is inimical to effective care. As with 
Gabbay and le May,33 the present study points to the inter- 
relationship of patient–practitioner mindlines. Our find-
ings are in accordance with and extend the findings of 
Gabbay and le May33 who suggest that in a consultation 
two sets of mindlines converge as a single instantiation, 
which is co- constructed during in the encounter. Our 
study reveals the need to manage this influence directly if 
eczema care is to improve, a more definitive call than the 
hint at social influences on healthcare and actions that 
subsequently occur.33
To date, little has been written about mindline 
amendment strategies; however, there are elements of 
our co- created approaches that are congruent with the 
existing literature. The need to provide clear, simple, 
‘real’ messages from trusted sources to a lay audience 
beyond those directly affected by eczema, but who 
may nevertheless influence use of treatments, can be 
grounded in the literature of social marketing (SM) in 
healthcare. SM amalgamates concepts from commercial 
marketing and social sciences; it goes beyond simply 
imparting knowledge widely and is intended to directly 
influence healthcare actions.47 SM in healthcare has 
been used internationally since the mid- 1970s48 and is 
considered a potential strategy to improve public health, 
for example, in reduction of smoking and obesity.49 It 
embraces health communication techniques based on 
mass media. Messages can be mediated through other 
sources, in our case potentially practitioners and lay influ-
encers. Communication approaches are varied and may 
include targeted message placement, promotion, dissem-
ination and community outreach.50 While evidence of the 
effectiveness of SM in healthcare remains sparse,51 it is 
argued that some elements have the potential to support 
lay mindline amendment, given the high prevalence of 
childhood eczema, the aim of changing behaviour and the 
need to get simple, consistent messages to a diverse range 
of people who have potential to influence treatment use 
(eg, grandparents, friends and informal contacts).
Approaches to practitioner mindline amendment 
need to offer ‘no faff’, locally relevant, tailored hints and 
tips. This need is driven both by the low priority given to 
eczema and the increasingly heavy workloads of primary 
care practitioners.52–55 Previous studies identify what is 
important to practitioners if messages are to influence 
their practice. Utility of information is measured by some 
in terms of relevance x validity÷work required to obtain 
it.56 Evidence suggests that to influence practice, knowl-
edge must (1) relate to the day- to- day challenge of having 
to manage this patient, at this time and in this situation,57 
(2) be accessible, understandable and enable practitioners 
to make a ‘good enough’ treatment decision and (3) fit 
with the particularities of the context.29 58 Knowledge 
that addresses these points allows practitioners to trans-
form it through contextual adroitness into knowledge- in- 
practice- in- context, which enables good clinical care.59 
Strategies to amend practitioner mindlines that take 
into account the needs outlined above may include, for 
example, use of aphorisms, that is, succinct sayings that 
offer advice and convey concentrated wisdom60 or in a 
similar vein to ‘actionable nuggets’, snippets of practical 
and memorable information that can be readily used in 
everyday practice.61
Although knowledge is essential, changing this facet 
of mindlines alone will not change eczema care. Power 
differentials between lay person and practitioner also 
need to be minimised. In agreement with the existing 
literature, our study concludes that knowledge is power62 
does not hold true in primary care eczema consultations. 
While practitioners often have access to more clinical 
information, patients are frequently experts in their own 
condition.63 In common with the existing literature, our 
group members agreed that when patients are engaged 
in healthcare decision- making, outcomes64 and levels 
of satisfaction65 improve. The core messages for all we 
designed offer common language66 and are intended 
to reduce ‘informational inequality’67 and thus improve 
shared understanding and agreed, realistic plans of care.
Efforts to influence the mindlines of all types of health-
care provider are intended to support consistency of 
information. This approach also addresses power imbal-
ances by widening the range of practitioners with whom 
lay people may choose to consult. Power imbalances 
are most frequently problematic in consultations with 
doctors, which begs the question whether they are best 
placed to provide eczema care. Eczema consultations 
with expert dermatology nurses are known to be highly 
valued by patients.68–71 However, there are few primary 
care dermatology nurses in post. There are suggestions 
that community pharmacists and pharmacy counter assis-
tants, who are often the first point of contact and who can 
offer advice independent of the pharmacist,72 are not yet 
being fully used.73–75
CONCLUSION
This study, as with previous research, emphasises the need 
to improve eczema primary care consultation experiences 
and self- management practices. As previously noted, 
approaches to date have predominantly been provision 
of educational and psychological interventions or the 
use of written action plans. The present study offers an 
alternative approach in mindline amendment in which 
simple, consistent, evidence- based knowledge is shared 
across patient–practitioner social boundaries to promote 
shared understanding and which, importantly, acknowl-
edges role of influential members of the wider commu-
nity. The challenge now is to take the five key messages, 
underpinned by hints and tips and convert them into 
a range of formats that can be shared among relevant 
parties. The impact of this intervention is intended to be 
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revision or modification of mindlines achieved by adding 
reliable and useful knowledge and erasing outdated or 
inaccurate information. Further research is needed to 
assess what bearing it has on primary care eczema consul-
tation experiences and self- management practices.
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